Please login to the form below

Not currently logged in
Email:
Password:

adverse events

This page shows the latest adverse events news and features for those working in and with pharma, biotech and healthcare.

Amarin files fish oil-based heart drug Vascepa in Europe

Amarin files fish oil-based heart drug Vascepa in Europe

REDUCE-IT showed that Vascepa achieved a reduction of 25% in major adverse cardiovascular events (MACE) and a 20% reduction in deaths in high-risk patients. ... with Vascepa “major adverse cardiovascular events such as stroke, heart attack and

Latest news

More from news
Approximately 4 fully matching, plus 316 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Behavioural Science in Healthcare
Personal health and wellbeing has never been more a part of the public conscious than it is now....
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...
Dec PME cover
Creativity in storytelling: why pharma must invest more in creativity
Chris Ross explores the value, the art and the much-rumoured death of creativity...

Infographics